206 related articles for article (PubMed ID: 17352267)
1. Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Derka S; Serefoglou Z; Vassiliou S; Nkenke E; Ragos V; Vylliotis A; Spyridonidou S; Tsigris C; Yannopoulos A; Tesseromatis C; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(1A):459-64. PubMed ID: 17352267
[TBL] [Abstract][Full Text] [Related]
2. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Vasiliou S; Derka S; Nkenke E; Serefoglou Z; Vorris E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4095-100. PubMed ID: 18225577
[TBL] [Abstract][Full Text] [Related]
3. A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Vassiliou S; Nkenke E; Serefoglou Z; Derka S; Tsigris C; Vylliotis A; Yapijakis C; Neukam FW; Patsouris E
Eur J Surg Oncol; 2008 Apr; 34(4):450-5. PubMed ID: 17498910
[TBL] [Abstract][Full Text] [Related]
4. A metalloproteinase-13 polymorphism affecting its gene expression is associated with advanced stages of oral cancer.
Vairaktaris E; Yapijakis C; Nkenke E; Serefoglou ZC; Chatzitheofylaktou A; Vassiliou S; Derka S; Vylliotis A; Perrea D; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4027-30. PubMed ID: 18225566
[TBL] [Abstract][Full Text] [Related]
5. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
6. High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
Vairaktaris E; Serefoglou Z; Yapijakis C; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(4B):2493-8. PubMed ID: 17695544
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.
Su L; Zhou W; Park S; Wain JC; Lynch TJ; Liu G; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):567-70. PubMed ID: 15767330
[TBL] [Abstract][Full Text] [Related]
8. Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population.
Albayrak S; Cangüven O; Göktaş C; Aydemir H; Köksal V
Urol Int; 2007; 79(4):312-5. PubMed ID: 18025848
[TBL] [Abstract][Full Text] [Related]
9. The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Wiltfang J; Avgoustidis D; Critselis E; Neukam FW; Patsouris E
Eur J Surg Oncol; 2007 May; 33(4):504-7. PubMed ID: 17174061
[TBL] [Abstract][Full Text] [Related]
10. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer].
Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM
Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875
[TBL] [Abstract][Full Text] [Related]
11. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
[TBL] [Abstract][Full Text] [Related]
12. Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas.
Lin SC; Chung MY; Huang JW; Shieh TM; Liu CJ; Chang KW
J Oral Pathol Med; 2004 Jul; 33(6):323-6. PubMed ID: 15200479
[TBL] [Abstract][Full Text] [Related]
13. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
[TBL] [Abstract][Full Text] [Related]
14. The platelet glycoprotein Ibalpha VNTR polymorphism is associated with risk for oral cancer.
Vairaktaris E; Serefoglou ZC; Yapijakis C; Vassiliou S; Nkenke E; Avgoustidis D; Vylliotis A; Stathopoulos P; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4121-5. PubMed ID: 18225582
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P
Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394
[TBL] [Abstract][Full Text] [Related]
16. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
[TBL] [Abstract][Full Text] [Related]
17. Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
Hashimoto T; Uchida K; Okayama N; Imate Y; Suehiro Y; Hamanaka Y; Ueyama Y; Shinozaki F; Yamashita H; Hinoda Y
Cancer Lett; 2004 Jul; 211(1):19-24. PubMed ID: 15194213
[TBL] [Abstract][Full Text] [Related]
18. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Tsigris C; Vassiliou S; Derka S; Nkenke E; Spyridonidou S; Vylliotis A; Vorris E; Ragos V; Neukam FW; Patsouris E
Acta Oncol; 2007; 46(8):1097-102. PubMed ID: 17851834
[TBL] [Abstract][Full Text] [Related]
19. The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population.
Kouhkan F; Motovali-Bashi M; Hojati Z
Cancer Invest; 2008 Oct; 26(8):836-42. PubMed ID: 18798060
[TBL] [Abstract][Full Text] [Related]
20. Angiotensinogen polymorphism is associated with risk for malignancy but not for oral cancer.
Vairaktaris E; Yapijakis C; Vylliotis A; Derka S; Vassiliou S; Nkenke E; Serefoglou Z; Ragos V; Critselis E; Avgoustidis D; Neukam F; Patsouris E
Anticancer Res; 2008; 28(3A):1675-9. PubMed ID: 18630525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
